Newly published results from a multinational study co-authored by Kenneth Ataga, MD, director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) and the Memphis Consortium for Sickle Cell Disease and Non-Malignant Hematology Research, indicated voxelotor, a novel experimental drug for sickle cell disease, reduced anemia and boosted… Read More
Message from the Chancellor: I am pleased to report the University of Tennessee Board of Trustees approved the UTHSC budget at their meeting this past Friday, June 21. As I articulated in our recent Town Hall, “It is a good, but challenging budget year.” Key points: Tuition was held to increases of only $200 per… Read More
Retinal neovascularization (RNV) occurs when new blood vessels grow on the surface of the retina. While wound repair in the skin and many other tissues involves neovascularization, in the eye, neovascularization can cause severe vision loss and blindness. Nikhlesh K. Singh, DVM, PhD, assistant professor in the Department of Physiology in the College of Medicine at… Read More